Patent · US Active

Formulations of low dose diclofenac and beta-cyclodextrin

US8580954B2 · kind B2 · utility

3Cited by
38References
4Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 22, 2007
Grant dateNov 12, 2013
Priority date
Expiry dateJun 15, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC08B37/0015
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to a pharmaceutical composition containing a unit dose of a diclofenac compound effective to induce analgesia; and a beta-cyclodextrin compound; wherein the dose of the diclofenac compound is less than 10 mg. The present invention is also directed to methods of treating a subject in need of analgesia with the pharmaceutical compositions of the invention.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.